Recent News

• 09.09.2025 - Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.02.2025 - Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 09.02.2025 - Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
• 08.06.2025 - Q2 2025 Lantheus Earnings Conference Call
• 08.06.2025 - Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.06.2025 - Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
• 08.06.2025 - Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
• 08.06.2025 - Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent

Recent Filings

• 08.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.18.2025 - 3 Initial statement of beneficial ownership of securities
• 08.18.2025 - 3 Initial statement of beneficial ownership of securities
• 08.18.2025 - 3 Initial statement of beneficial ownership of securities
• 08.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 144 Report of proposed sale of securities